HOMOCYSTEINE AND VASCULAR ACCESS THROMBOSIS IN HEMODIALYSIS PATIENTS

REFERENCES

• Mysliwiec M. Vascular Access Thrombosis—What Are the Possibilities of Intervention?. Nephrol. Dial. Transplant. 1997; 12(5)876–878
   Google Scholar
• Fan P.Y., Schwab S.J. Vascular Access: Concepts for the 1990s. J. Am. Soc. Nephrol. 1992; 3(1)1–11
   Google Scholar
• Culp K., Flanigan M., Taylor L., Rothstein M. Vascular Access Thrombosis in New Hemodialysis Patients. Am. J. Kidney Dis. 1995; 26(2)341–346
   Google Scholar
• NKF-DOQI Clinical Practice Guidelines for Vascular Access. Am. J. Kidney Dis. 1997; 30: S150–189
   Google Scholar
• Feldman H.I., Kobrin S., Wasserstein A. Hemodialysis Vascular Access Morbidity. J. Am. Soc. Nephrol. 1996; 7(4)523–535
   Google Scholar
• Woods J.D., Turenne M.N., Strawderman R.L., Young E.W., Hirth R.A., Port F.K., Held P.J. Vascular Access Survival Among Incident Hemodialysis Patients in the United States. Am. J. Kidney Dis. 1997; 30(1)50–57
   Google Scholar
• Windus D.W., Jendrisak M.D., Delmez J.A. Prosthetic Fistula Survival and Complications in Hemodialysis Patients: Effects of Diabetes and Age. Am. J. Kidney Dis. 1992; 19(5)448–452
   Google Scholar
• Churchill D.N., Taylor D.W., Cook R.J., LaPlante P., Barre P., Cartier P., Fay W.P., Goldstein M.B., Jindal K., Mandin H. Canadian Hemodialysis Morbidity Study. Am. J. Kidney Dis. 1992; 19(3)214–234
   Google Scholar
• Goldwasser P., Michel M.A., Collier J., Mittman N., Fein P.A., Gusik S.A., Avram M.M. Prealbumin and Lipoprotein(a) in Hemodialysis: Relationships with Patient and Vascular Access Survival. Am. J. Kidney Dis. 1993; 22(1)215–225
   Google Scholar
• Hojs R., Dvoršak B., Ekart R., Pečovnik-Balon B. Lipids Abnormalities—Risk Factor for Hemodialysis Vascular Access Thrombosis?. Proceedings of the 2nd International Multidisciplinary Symposium Angioaccess for Hemodialysis, ToursFrance, May 31–June 2, 1999, 119
   Google Scholar
• Prakash R., Miller C.C., III, Suki W.N. Anticardiolipin Antibody in Patients on Maintenance Hemodialysis and its Association with Recurrent Arteriovenous Graft Thrombosis. Am. J. Kidney Dis. 1995; 6(2)347–352
   Google Scholar
• Brunet P., Aillaud M.F., San Marco M., Philip-Joet C., Dussol B., Bernard D., Juhan-Vague I., Berland Y. Antiphospholipids in Hemodialysis Patients: Relationship Between Lupus Anticoagulant and Thrombosis. Kidney Int. 1995; 48(3)794–800
   Google Scholar
• Taniguchi Y., Yorioka N., Oda H., Masaki T., Usui K., Harada S., Yamakido M. Plasma Thrombomodulin: Usefulness as a Blood Access Failure Marker in Hemodialysis Patients. Nephron. 1996; 73(1)91–93
   Google Scholar
• Falcon C.R., Cattaneo M., Panzeri D., Martinelli I., Mannucci M. High Prevalence of Hyperhomocyst(e)inemia in Patients with Juvenile Venous Thrombosis. Arterioscler. Thromb. 1994; 14(7)1080–1083
   Google Scholar
• den Heijer M., Blom H.J., Gerrits W.B., Rosendaal F.R., Haak H.L., Wijermans P.W., Bos G.M. Is Hyperhomocystinemia a Risk Factor for Recurrent Venous Thrombosis?. Lancet 1995; 345(8954)882–885
   Google Scholar
• Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., Graham I. Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease. N. Engl. J. Med. 1991; 324(17)1149–1155
   Google Scholar
• Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease. Probable Benefits of Increasing Folic Acid Intakes. JAMA 1995; 274(13)1049–1057
   Google Scholar
• den Heijer M., Koster T., Blom H.J., Bos G.M., Briet E., Reitsma P.H., Vandenbroucke J.P., Rosendaal F.R. Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis. N. Engl. J. Med. 1996; 334(12)759–762
   Google Scholar
• Bostom A.G., Lathrop L. Hyperhomocysteinemia in End-Stage Renal Disease: Prevalence, Etiology, and Potential Relationship to Arteriosclerotic Outcomes. Kidney Int. 1997; 52(1)10–20
   Google Scholar
• Bostom A.G., Shemin D., Lapane K.L., Miller J.W., Sutherland P., Nadeau M., Seyoum E., Hartman W., Prior R., Wilson P.W. Hyperhomocysteinemia and Traditional Cardiovascular Disease Risk Factors in End-Stage Renal Disease Patients on Dialysis: A Case-Control Study. Atherosclerosis 1995; 114(1)93–103
   Google Scholar
• Moustapha A., Gupta A., Robinson K., Arheart K., Jacobsen D.W., Schreiber M.J., Dennis V.W. Prevalence and Determinants of Hyperhomocysteinemia in Hemodialysis and Peritoneal Dialysis. Kidney Int. 1999; 55(4)1470–1475
   Google Scholar
• Bostom A.G., Shemin D., Lapane K.L., Hume A.L., Yoburn D., Nadeau M.R., Bendich A., Selhub J., Rosenberg I.H. High Dose-B-Vitamin Treatment of Hyperhomocysteinemia in Dialysis Patients. Kidney Int. 1996; 49(1)147–152
   Google Scholar
• Dennis V.W., Robinson K. Homocysteinemia and Vascular Disease in End-Stage Renal Disease. Kidney Int. Suppl. 1996; 57: S11–S17
   Google Scholar
• Rosenthal A.F., Ginsburg N.J., Crawford J.F. Homocysteine and Heart Disease in Dialysis Patients. Dialysis Transplantation 1998; 27(10)627–629
   Google Scholar
• Bostom A.G., Shemin D., Verhoef P., Nadeau M.R., Jacques P.F., Selhub J., Dworkin L., Rosenberg I.H. Elevated Fasting Total Plasma Homocysteine Levels and Cardiovascular Disease Outcomes in Maintenance Dialysis Patients. A Prospective Study. Arterioscler. Thromb. Vasc. Biol. 1997; 17(11)2554–2558
   Google Scholar
• Moustapha A., Naso A., Nahlawi M., Gupta A., Arheart K.L., Jacobsen D.W., Robinson K., Dennis V.W. Prospective Study of Hyperhomocysteinemia as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease. Circulation 1998; 97(2)138–141
   Google Scholar
• Kunz K., Petitjean P., Lisri M., Chantrel F., Koehl C., Wiesel M.L., Cazenave J.P., Moulin B., Hannedouche T.P. Cardiovascular Morbidity and Endothelial Dysfunction in Chronic Haemodialysis Patients: Is Homocyst(e)ine the Missing Link?. Nephrol. Dial. Transplant. 1999; 14(8)1934–1942
   Google Scholar
• Hultberg B., Andersson A., Sterner G. Plasma Homocysteine in Renal Failure. Clin. Nephrol. 1993; 40(4)230–234
   Google Scholar
• Sirrs S., Duncan L., Djurdjev O., Nussbaumer G., Ganz G., Frohlich J., Levin A. Homocyst(e)ine and Vascular Access Complications in Haemodialysis Patients: Insights into a Complex Metabolic Relationship. Nephrol. Dial. Transplant. 1999; 14(3)738–743
   Google Scholar
• Wilcken D.E., Gupta V.J. Sulphur Containing Amino Acids in Chronic Renal Failure with Particular References to Homocysteine and Cysteine-Homocysteine Mixed Disulphide. Eur. J. Clin. Invest. 1979; 9(4)301–317
   Google Scholar
• Hong S.Y., Yang D.H., Chang S.K. Plasma Homocysteine, Vitamin B6, Vitamin B12 and Folic Acid in End-Stage Renal Disease During Low Dose Supplementation with Folic Acid. Am. J. Nephrol. 1998; 18(5)367–372
   Google Scholar
• Arnadottir M., Brattstrom L., Simonsen O., Thysell H., Hultberg B., Andersson A., Nilsson-Ehle P. The Effect of High Dose Pyridoxine and Folic Acid Supplementation on Serum Lipid and Plasma Homocysteine Concentrations in Dialysis Patients. Clin. Nephrol. 1993; 40(4)236–240
   Google Scholar
• Arnadottir M., Hultenberg B., Wahlberg J., Fellström B., Dimeny E. Serum Total Homocysteine Concentrations Before and After Renal Transplantation. Kidney Int. 1998; 54(4)1380–1384
   Google Scholar
• Jacques P.F., Selhub J., Rosenberg H. Hyperhomocystinemia, Hyperfibrinogenemia and Lipoprotein (a) Excess in Maintenance Dialysis Patients: A Matched Case-Control Study. Atherosclerosis 1996; 125(1)91–101
   Google Scholar
• Fermo I., D’Angelo S.V., Paroni R., Mazzola G., Calori G., D’Angelo A. Prevalence of Moderate Hyperhomocystinemia in Patients with Early-Onset Venous and Arterial Occlusive Disease. Ann. Intern. Med. 1995; 123(10)747–753
   Google Scholar
• Manns B.J., Burgess E.D., Parsons H.G., Schaefer J.P., Hyndman M.E., Scott-Douglas N.W. Hyperhomocystinemia, Anticardiolipin Antibody Status, and Risk for Vascular Access Thrombosis in Hemodialysis Patients. Kidney Int. 1999; 55(1)315–320
   Google Scholar
• Tamura T., Bergman S.M., Morgan S.L. Homocysteine,B Vitamins, and Vascular Access Thrombosis in Patients Treated with Hemodialysis. Am. J. Kidney Dis. 1998; 32(3)475–481
   Google Scholar
• Shemin D., Lapane K.L., Bausserman L., Kanaan E., Kahn S., Dworkin L., Bostom A.G. Plasma Total Homocysteine and Hemodialysis Access Thrombosis: A Prospective Study. J. Am. Soc. Nephrol. 1999; 10(5)1095–1099
   Google Scholar
• Ducloux D., Pascal B., Jamali M., Gibney R., Chalopin J.M. Is Hyperhomocystinemia a Risk Factor for Recurrent Vascular Access Thrombosis in Hemodialysis Patients?. Nephrol. Dial. Transplant. 1997; 12(9)2037–2038
   Google Scholar
• Selhub J., D’Angelo A. Hyperhomocystinemia and Thrombosis: Acquired Conditions. Thromb. Hemost. 1997; 78(1)527–531
   Google Scholar